New York-based fund emerges as Rubicon investor with 7.5% stake

Mon, 09 Jul 2012

By Paul McBeth July 10 (BusinessDesk) - Sophrosyne Capital, a New York-based fund manager, has emerged with a 7.5 percent in Rubicon after doubling the size of its investment in the New Zealand forestry biotech firm’s recent rights issue. The privately-held fund manager bought 700,000 shares, or 3.4 percent, for almost $260,000 in March, and subsequently subscribed for an extra 18.7 million shares for some US$3.3 million in this month's rights issue, according to a substantial shareholder notice. Rubicon raised $21 million in a fully-subscri...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets market close
NZ sharemarket rebounds with Wall Street rally
Dan Brunskill | Mon, 27 Jun 2022

US markets rallied on Friday night as traders began thinking an economic slowdown would stop the US Federal Reserve from hiking interest rates.

Policy
Political donations over $5k to require declaration
Staff reporters | Mon, 27 Jun 2022

The changes require disclosure of donor identities for any party donations over $5,000 versus the current $15,000. 

Law & Regulation
Public class action fund needed: Law Com
Victoria Young | Mon, 27 Jun 2022

The Law Commission has finalised its report into class actions and litigation funding.

Sponsored
Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.

Sponsored
High water marks: Watercare raises the tide on sustainability

The No.1 barrier to decarbonisation for NZ organisations is accurate measurement, says Microsoft’s Accelerating the Journey to Net Zero report.